GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
TCF12
|
ENSG00000140262.13 | transcription factor 12 |
ASCL2
|
ENSG00000183734.4 | achaete-scute family bHLH transcription factor 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TCF12 | hg19_v2_chr15_+_57210961_57211030 | -0.42 | 1.2e-10 | Click! |
ASCL2 | hg19_v2_chr11_-_2292182_2292212 | 0.26 | 1.3e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr22_+_23241661 | 51.21 |
ENST00000390322.2
|
IGLJ2
|
immunoglobulin lambda joining 2 |
chr21_-_46330545 | 47.96 |
ENST00000320216.6
ENST00000397852.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr16_+_23847339 | 46.70 |
ENST00000303531.7
|
PRKCB
|
protein kinase C, beta |
chr16_+_23847267 | 41.00 |
ENST00000321728.7
|
PRKCB
|
protein kinase C, beta |
chr22_+_22707260 | 34.83 |
ENST00000390293.1
|
IGLV5-48
|
immunoglobulin lambda variable 5-48 (non-functional) |
chr22_-_37882395 | 33.02 |
ENST00000416983.3
ENST00000424765.2 ENST00000356998.3 |
MFNG
|
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
chr2_+_90273679 | 29.89 |
ENST00000423080.2
|
IGKV3D-7
|
immunoglobulin kappa variable 3D-7 |
chr15_+_89182178 | 29.87 |
ENST00000559876.1
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr4_+_154387480 | 29.44 |
ENST00000409663.3
ENST00000440693.1 ENST00000409959.3 |
KIAA0922
|
KIAA0922 |
chr5_+_156693091 | 27.76 |
ENST00000318218.6
ENST00000442283.2 ENST00000522463.1 ENST00000521420.1 |
CYFIP2
|
cytoplasmic FMR1 interacting protein 2 |
chr15_+_89181974 | 27.66 |
ENST00000306072.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr2_-_89278535 | 24.75 |
ENST00000390247.2
|
IGKV3-7
|
immunoglobulin kappa variable 3-7 (non-functional) |
chr15_+_74833518 | 24.37 |
ENST00000346246.5
|
ARID3B
|
AT rich interactive domain 3B (BRIGHT-like) |
chr2_-_90538397 | 23.93 |
ENST00000443397.3
|
RP11-685N3.1
|
Uncharacterized protein |
chr3_+_49507674 | 23.84 |
ENST00000431960.1
ENST00000452317.1 ENST00000435508.2 ENST00000452060.1 ENST00000428779.1 ENST00000419218.1 ENST00000430636.1 |
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1) |
chr5_-_150603679 | 22.70 |
ENST00000355417.2
|
CCDC69
|
coiled-coil domain containing 69 |
chr2_-_89327228 | 22.65 |
ENST00000483158.1
|
IGKV3-11
|
immunoglobulin kappa variable 3-11 |
chr10_-_103347883 | 22.51 |
ENST00000339310.3
ENST00000370158.3 ENST00000299206.4 ENST00000456836.2 ENST00000413344.1 ENST00000429502.1 ENST00000430045.1 ENST00000370172.1 ENST00000436284.2 ENST00000370162.3 |
POLL
|
polymerase (DNA directed), lambda |
chr22_+_23247030 | 22.22 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
chr17_+_34431212 | 22.11 |
ENST00000394495.1
|
CCL4
|
chemokine (C-C motif) ligand 4 |
chr15_+_89182156 | 22.10 |
ENST00000379224.5
|
ISG20
|
interferon stimulated exonuclease gene 20kDa |
chr11_-_33891362 | 21.85 |
ENST00000395833.3
|
LMO2
|
LIM domain only 2 (rhombotin-like 1) |
chr16_-_89043377 | 21.71 |
ENST00000436887.2
ENST00000448839.1 ENST00000360302.2 |
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
chr2_+_87565634 | 21.52 |
ENST00000421835.2
|
IGKV3OR2-268
|
immunoglobulin kappa variable 3/OR2-268 (non-functional) |
chr1_-_27961720 | 21.47 |
ENST00000545953.1
ENST00000374005.3 |
FGR
|
feline Gardner-Rasheed sarcoma viral oncogene homolog |
chr14_-_106322288 | 21.37 |
ENST00000390559.2
|
IGHM
|
immunoglobulin heavy constant mu |
chr6_-_24911195 | 21.18 |
ENST00000259698.4
|
FAM65B
|
family with sequence similarity 65, member B |
chr20_+_37434329 | 20.83 |
ENST00000299824.1
ENST00000373331.2 |
PPP1R16B
|
protein phosphatase 1, regulatory subunit 16B |
chr22_+_23264766 | 20.17 |
ENST00000390331.2
|
IGLC7
|
immunoglobulin lambda constant 7 |
chr7_-_100171270 | 20.14 |
ENST00000538735.1
|
SAP25
|
Sin3A-associated protein, 25kDa |
chr2_-_89292422 | 20.10 |
ENST00000495489.1
|
IGKV1-8
|
immunoglobulin kappa variable 1-8 |
chr6_-_32634425 | 19.78 |
ENST00000399082.3
ENST00000399079.3 ENST00000374943.4 ENST00000434651.2 |
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1 |
chr15_+_75118888 | 19.71 |
ENST00000395018.4
|
CPLX3
|
complexin 3 |
chr9_-_35619539 | 19.48 |
ENST00000396757.1
|
CD72
|
CD72 molecule |
chr2_+_90060377 | 18.40 |
ENST00000436451.2
|
IGKV6D-21
|
immunoglobulin kappa variable 6D-21 (non-functional) |
chr12_-_15103621 | 18.34 |
ENST00000536592.1
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chr14_-_107114267 | 18.12 |
ENST00000454421.2
|
IGHV3-64
|
immunoglobulin heavy variable 3-64 |
chr11_-_73694346 | 17.88 |
ENST00000310473.3
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier) |
chr5_+_156693159 | 17.87 |
ENST00000347377.6
|
CYFIP2
|
cytoplasmic FMR1 interacting protein 2 |
chr2_+_90108504 | 17.73 |
ENST00000390271.2
|
IGKV6D-41
|
immunoglobulin kappa variable 6D-41 (non-functional) |
chr21_+_10862622 | 17.57 |
ENST00000302092.5
ENST00000559480.1 |
IGHV1OR21-1
|
immunoglobulin heavy variable 1/OR21-1 (non-functional) |
chr11_+_128634589 | 17.12 |
ENST00000281428.8
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor |
chr2_-_158345462 | 17.11 |
ENST00000439355.1
ENST00000540637.1 |
CYTIP
|
cytohesin 1 interacting protein |
chr2_+_90211643 | 17.06 |
ENST00000390277.2
|
IGKV3D-11
|
immunoglobulin kappa variable 3D-11 |
chr1_+_156119798 | 16.39 |
ENST00000355014.2
|
SEMA4A
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
chr16_-_89043605 | 16.18 |
ENST00000268679.4
|
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
chr19_+_18794470 | 16.18 |
ENST00000321949.8
ENST00000338797.6 |
CRTC1
|
CREB regulated transcription coactivator 1 |
chr22_+_41777927 | 16.06 |
ENST00000266304.4
|
TEF
|
thyrotrophic embryonic factor |
chr11_+_1874200 | 15.92 |
ENST00000311604.3
|
LSP1
|
lymphocyte-specific protein 1 |
chr2_-_89619904 | 15.81 |
ENST00000498574.1
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 (gene/pseudogene) |
chr14_-_106692191 | 15.78 |
ENST00000390607.2
|
IGHV3-21
|
immunoglobulin heavy variable 3-21 |
chr11_+_117857063 | 15.67 |
ENST00000227752.3
ENST00000541785.1 ENST00000545409.1 |
IL10RA
|
interleukin 10 receptor, alpha |
chr20_+_44637526 | 15.66 |
ENST00000372330.3
|
MMP9
|
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
chr2_+_68961934 | 15.61 |
ENST00000409202.3
|
ARHGAP25
|
Rho GTPase activating protein 25 |
chr2_+_90121477 | 15.56 |
ENST00000483379.1
|
IGKV1D-17
|
immunoglobulin kappa variable 1D-17 |
chr2_-_89340242 | 15.52 |
ENST00000480492.1
|
IGKV1-12
|
immunoglobulin kappa variable 1-12 |
chr14_-_106963409 | 15.51 |
ENST00000390621.2
|
IGHV1-45
|
immunoglobulin heavy variable 1-45 |
chr17_+_38083977 | 15.39 |
ENST00000578802.1
ENST00000578478.1 ENST00000582263.1 |
RP11-387H17.4
|
RP11-387H17.4 |
chr16_-_31214051 | 15.37 |
ENST00000350605.4
|
PYCARD
|
PYD and CARD domain containing |
chr3_-_18480260 | 15.34 |
ENST00000454909.2
|
SATB1
|
SATB homeobox 1 |
chr22_-_23922448 | 15.17 |
ENST00000438703.1
ENST00000330377.2 |
IGLL1
|
immunoglobulin lambda-like polypeptide 1 |
chr17_+_34430980 | 15.13 |
ENST00000250151.4
|
CCL4
|
chemokine (C-C motif) ligand 4 |
chr2_+_90139056 | 15.05 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
chr2_+_68961905 | 14.99 |
ENST00000295381.3
|
ARHGAP25
|
Rho GTPase activating protein 25 |
chr20_+_62367989 | 14.49 |
ENST00000309546.3
|
LIME1
|
Lck interacting transmembrane adaptor 1 |
chr6_-_32731299 | 14.48 |
ENST00000435145.2
ENST00000437316.2 |
HLA-DQB2
|
major histocompatibility complex, class II, DQ beta 2 |
chr1_-_169680745 | 14.42 |
ENST00000236147.4
|
SELL
|
selectin L |
chr7_+_150498610 | 14.16 |
ENST00000461345.1
|
TMEM176A
|
transmembrane protein 176A |
chr5_-_149792295 | 14.10 |
ENST00000518797.1
ENST00000524315.1 ENST00000009530.7 ENST00000377795.3 |
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain |
chr16_+_32077386 | 14.08 |
ENST00000354689.6
|
IGHV3OR16-9
|
immunoglobulin heavy variable 3/OR16-9 (non-functional) |
chr2_+_69001913 | 14.06 |
ENST00000409030.3
ENST00000409220.1 |
ARHGAP25
|
Rho GTPase activating protein 25 |
chr3_+_121554046 | 14.01 |
ENST00000273668.2
ENST00000451944.2 |
EAF2
|
ELL associated factor 2 |
chr2_+_90198535 | 14.00 |
ENST00000390276.2
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
chr22_-_23922410 | 13.89 |
ENST00000249053.3
|
IGLL1
|
immunoglobulin lambda-like polypeptide 1 |
chrX_-_107019181 | 13.75 |
ENST00000315660.4
ENST00000372384.2 ENST00000502650.1 ENST00000506724.1 |
TSC22D3
|
TSC22 domain family, member 3 |
chr14_-_107131560 | 13.68 |
ENST00000390632.2
|
IGHV3-66
|
immunoglobulin heavy variable 3-66 |
chr5_-_1295104 | 13.67 |
ENST00000334602.6
ENST00000508104.2 ENST00000310581.5 ENST00000296820.5 |
TERT
|
telomerase reverse transcriptase |
chr7_+_72848092 | 13.63 |
ENST00000344575.3
|
FZD9
|
frizzled family receptor 9 |
chr14_-_106781017 | 13.39 |
ENST00000390612.2
|
IGHV4-28
|
immunoglobulin heavy variable 4-28 |
chr14_-_107170409 | 13.27 |
ENST00000390633.2
|
IGHV1-69
|
immunoglobulin heavy variable 1-69 |
chr1_-_92951607 | 13.25 |
ENST00000427103.1
|
GFI1
|
growth factor independent 1 transcription repressor |
chr3_-_194991876 | 13.23 |
ENST00000310380.6
|
XXYLT1
|
xyloside xylosyltransferase 1 |
chr2_-_89442621 | 13.18 |
ENST00000492167.1
|
IGKV3-20
|
immunoglobulin kappa variable 3-20 |
chr1_+_111772314 | 13.13 |
ENST00000466741.1
ENST00000477185.2 |
CHI3L2
|
chitinase 3-like 2 |
chr14_-_106878083 | 13.04 |
ENST00000390619.2
|
IGHV4-39
|
immunoglobulin heavy variable 4-39 |
chr5_+_66124590 | 12.85 |
ENST00000490016.2
ENST00000403666.1 ENST00000450827.1 |
MAST4
|
microtubule associated serine/threonine kinase family member 4 |
chr17_-_35969409 | 12.82 |
ENST00000394378.2
ENST00000585472.1 ENST00000591288.1 ENST00000502449.2 ENST00000345615.4 ENST00000346661.4 ENST00000585689.1 ENST00000339208.6 |
SYNRG
|
synergin, gamma |
chr2_-_24583583 | 12.81 |
ENST00000355123.4
|
ITSN2
|
intersectin 2 |
chr19_-_10333842 | 12.75 |
ENST00000317726.4
|
CTD-2369P2.2
|
CTD-2369P2.2 |
chr17_-_3867585 | 12.70 |
ENST00000359983.3
ENST00000352011.3 ENST00000397043.3 ENST00000397041.3 ENST00000397035.3 ENST00000397039.1 ENST00000309890.7 |
ATP2A3
|
ATPase, Ca++ transporting, ubiquitous |
chr14_-_106926724 | 12.64 |
ENST00000434710.1
|
IGHV3-43
|
immunoglobulin heavy variable 3-43 |
chr11_+_34460447 | 12.64 |
ENST00000241052.4
|
CAT
|
catalase |
chrX_-_118827333 | 12.62 |
ENST00000360156.7
ENST00000354228.4 ENST00000489216.1 ENST00000354416.3 ENST00000394610.1 ENST00000343984.5 |
SEPT6
|
septin 6 |
chr1_+_24882560 | 12.60 |
ENST00000374392.2
|
NCMAP
|
noncompact myelin associated protein |
chr19_+_850985 | 12.47 |
ENST00000590230.1
|
ELANE
|
elastase, neutrophil expressed |
chr19_-_47164386 | 12.46 |
ENST00000391916.2
ENST00000410105.2 |
DACT3
|
dishevelled-binding antagonist of beta-catenin 3 |
chr3_+_182511266 | 12.40 |
ENST00000323116.5
ENST00000493826.1 |
ATP11B
|
ATPase, class VI, type 11B |
chr12_+_7055767 | 12.35 |
ENST00000447931.2
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr2_-_89399845 | 12.27 |
ENST00000479981.1
|
IGKV1-16
|
immunoglobulin kappa variable 1-16 |
chr17_+_34538310 | 12.23 |
ENST00000444414.1
ENST00000378350.4 ENST00000389068.5 ENST00000588929.1 ENST00000589079.1 ENST00000589336.1 ENST00000400702.4 ENST00000591167.1 ENST00000586598.1 ENST00000591637.1 ENST00000378352.4 ENST00000358756.5 |
CCL4L1
|
chemokine (C-C motif) ligand 4-like 1 |
chr2_+_90248739 | 11.97 |
ENST00000468879.1
|
IGKV1D-43
|
immunoglobulin kappa variable 1D-43 |
chr14_-_106539557 | 11.96 |
ENST00000390599.2
|
IGHV1-8
|
immunoglobulin heavy variable 1-8 |
chr19_+_1071203 | 11.83 |
ENST00000543365.1
|
HMHA1
|
histocompatibility (minor) HA-1 |
chr7_+_50344289 | 11.71 |
ENST00000413698.1
ENST00000359197.5 ENST00000331340.3 ENST00000357364.4 ENST00000343574.5 ENST00000349824.4 ENST00000346667.4 ENST00000440768.2 |
IKZF1
|
IKAROS family zinc finger 1 (Ikaros) |
chr15_+_31658349 | 11.70 |
ENST00000558844.1
|
KLF13
|
Kruppel-like factor 13 |
chr22_+_37257015 | 11.67 |
ENST00000447071.1
ENST00000248899.6 ENST00000397147.4 |
NCF4
|
neutrophil cytosolic factor 4, 40kDa |
chr2_+_89923550 | 11.67 |
ENST00000509129.1
|
IGKV1D-37
|
immunoglobulin kappa variable 1D-37 (non-functional) |
chr1_+_28206150 | 11.66 |
ENST00000456990.1
|
THEMIS2
|
thymocyte selection associated family member 2 |
chr12_+_50355647 | 11.66 |
ENST00000293599.6
|
AQP5
|
aquaporin 5 |
chr10_-_73848764 | 11.59 |
ENST00000317376.4
ENST00000412663.1 |
SPOCK2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
chr12_+_54892550 | 11.49 |
ENST00000545638.2
|
NCKAP1L
|
NCK-associated protein 1-like |
chrX_-_107018969 | 11.41 |
ENST00000372383.4
|
TSC22D3
|
TSC22 domain family, member 3 |
chr14_+_75746340 | 11.40 |
ENST00000555686.1
ENST00000555672.1 |
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
chr7_-_767249 | 11.39 |
ENST00000403562.1
|
PRKAR1B
|
protein kinase, cAMP-dependent, regulatory, type I, beta |
chr9_+_123837223 | 11.20 |
ENST00000373855.1
|
CNTRL
|
centriolin |
chr1_-_154928562 | 11.16 |
ENST00000368463.3
ENST00000539880.1 ENST00000542459.1 ENST00000368460.3 ENST00000368465.1 |
PBXIP1
|
pre-B-cell leukemia homeobox interacting protein 1 |
chr22_-_51021397 | 11.12 |
ENST00000406938.2
|
CHKB
|
choline kinase beta |
chr2_-_87017985 | 11.01 |
ENST00000352580.3
|
CD8A
|
CD8a molecule |
chr4_+_74718906 | 11.00 |
ENST00000226524.3
|
PF4V1
|
platelet factor 4 variant 1 |
chr6_-_31550192 | 10.97 |
ENST00000429299.2
ENST00000446745.2 |
LTB
|
lymphotoxin beta (TNF superfamily, member 3) |
chr1_-_31230650 | 10.96 |
ENST00000294507.3
|
LAPTM5
|
lysosomal protein transmembrane 5 |
chr12_+_7055631 | 10.95 |
ENST00000543115.1
ENST00000399448.1 |
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr1_+_60280458 | 10.94 |
ENST00000455990.1
ENST00000371208.3 |
HOOK1
|
hook microtubule-tethering protein 1 |
chr2_-_89266286 | 10.89 |
ENST00000464162.1
|
IGKV1-6
|
immunoglobulin kappa variable 1-6 |
chr1_-_154842741 | 10.87 |
ENST00000271915.4
|
KCNN3
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3 |
chr19_+_35521572 | 10.78 |
ENST00000262631.5
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
chr2_-_75426826 | 10.78 |
ENST00000305249.5
|
TACR1
|
tachykinin receptor 1 |
chr2_+_68962014 | 10.76 |
ENST00000467265.1
|
ARHGAP25
|
Rho GTPase activating protein 25 |
chr16_+_83932684 | 10.73 |
ENST00000262430.4
|
MLYCD
|
malonyl-CoA decarboxylase |
chr17_+_18163848 | 10.71 |
ENST00000323019.4
ENST00000578174.1 ENST00000395704.4 ENST00000395703.4 ENST00000578621.1 ENST00000579341.1 |
MIEF2
|
mitochondrial elongation factor 2 |
chr12_-_53601000 | 10.59 |
ENST00000338737.4
ENST00000549086.2 |
ITGB7
|
integrin, beta 7 |
chr13_+_50070491 | 10.54 |
ENST00000496612.1
ENST00000357596.3 ENST00000485919.1 ENST00000442195.1 |
PHF11
|
PHD finger protein 11 |
chr14_+_75746781 | 10.50 |
ENST00000555347.1
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
chr16_+_66914264 | 10.47 |
ENST00000311765.2
ENST00000568869.1 ENST00000561704.1 ENST00000568398.1 ENST00000566776.1 |
PDP2
|
pyruvate dehyrogenase phosphatase catalytic subunit 2 |
chr11_+_71249071 | 10.45 |
ENST00000398534.3
|
KRTAP5-8
|
keratin associated protein 5-8 |
chr9_-_136024721 | 10.43 |
ENST00000393160.3
|
RALGDS
|
ral guanine nucleotide dissociation stimulator |
chr2_-_89459813 | 10.36 |
ENST00000390256.2
|
IGKV6-21
|
immunoglobulin kappa variable 6-21 (non-functional) |
chr10_-_73848531 | 10.30 |
ENST00000373109.2
|
SPOCK2
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
chr15_-_75660919 | 10.29 |
ENST00000569482.1
ENST00000565683.1 ENST00000561615.1 ENST00000563622.1 ENST00000568374.1 ENST00000566256.1 ENST00000267978.5 |
MAN2C1
|
mannosidase, alpha, class 2C, member 1 |
chr5_+_75699040 | 10.23 |
ENST00000274364.6
|
IQGAP2
|
IQ motif containing GTPase activating protein 2 |
chr13_-_88323218 | 10.20 |
ENST00000436290.2
ENST00000453832.2 ENST00000606590.1 |
MIR4500HG
|
MIR4500 host gene (non-protein coding) |
chr9_-_97401782 | 10.19 |
ENST00000375326.4
|
FBP1
|
fructose-1,6-bisphosphatase 1 |
chr5_-_179285785 | 10.18 |
ENST00000520698.1
ENST00000518235.1 ENST00000376931.2 ENST00000518219.1 ENST00000521333.1 ENST00000523084.1 |
C5orf45
|
chromosome 5 open reading frame 45 |
chr19_-_45826125 | 10.15 |
ENST00000221476.3
|
CKM
|
creatine kinase, muscle |
chr17_+_34640031 | 10.14 |
ENST00000339270.6
ENST00000482104.1 |
CCL4L2
|
chemokine (C-C motif) ligand 4-like 2 |
chr9_+_37650945 | 10.14 |
ENST00000377765.3
|
FRMPD1
|
FERM and PDZ domain containing 1 |
chr12_-_53601055 | 10.10 |
ENST00000552972.1
ENST00000422257.3 ENST00000267082.5 |
ITGB7
|
integrin, beta 7 |
chr17_-_62009621 | 10.05 |
ENST00000349817.2
ENST00000392795.3 |
CD79B
|
CD79b molecule, immunoglobulin-associated beta |
chr7_-_139876812 | 10.05 |
ENST00000397560.2
|
JHDM1D
|
lysine (K)-specific demethylase 7A |
chr13_-_41635512 | 10.05 |
ENST00000405737.2
|
ELF1
|
E74-like factor 1 (ets domain transcription factor) |
chr15_+_91427642 | 10.03 |
ENST00000328850.3
ENST00000414248.2 |
FES
|
feline sarcoma oncogene |
chr5_+_75699149 | 10.00 |
ENST00000379730.3
|
IQGAP2
|
IQ motif containing GTPase activating protein 2 |
chr2_-_197036289 | 9.99 |
ENST00000263955.4
|
STK17B
|
serine/threonine kinase 17b |
chr1_+_22963158 | 9.91 |
ENST00000438241.1
|
C1QA
|
complement component 1, q subcomponent, A chain |
chr12_-_109027643 | 9.91 |
ENST00000388962.3
ENST00000550948.1 |
SELPLG
|
selectin P ligand |
chr5_+_49962772 | 9.80 |
ENST00000281631.5
ENST00000513738.1 ENST00000503665.1 ENST00000514067.2 ENST00000503046.1 |
PARP8
|
poly (ADP-ribose) polymerase family, member 8 |
chr16_-_4466622 | 9.78 |
ENST00000570645.1
ENST00000574025.1 ENST00000572898.1 ENST00000537233.2 ENST00000571059.1 ENST00000251166.4 |
CORO7
|
coronin 7 |
chr2_-_99552620 | 9.76 |
ENST00000428096.1
ENST00000397899.2 ENST00000420294.1 |
KIAA1211L
|
KIAA1211-like |
chr14_-_106642049 | 9.69 |
ENST00000390605.2
|
IGHV1-18
|
immunoglobulin heavy variable 1-18 |
chr17_-_62009702 | 9.57 |
ENST00000006750.3
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta |
chr5_+_169064245 | 9.57 |
ENST00000256935.8
|
DOCK2
|
dedicator of cytokinesis 2 |
chr4_+_40198527 | 9.57 |
ENST00000381799.5
|
RHOH
|
ras homolog family member H |
chr14_-_107219365 | 9.50 |
ENST00000424969.2
|
IGHV3-74
|
immunoglobulin heavy variable 3-74 |
chr19_+_33182823 | 9.48 |
ENST00000397061.3
|
NUDT19
|
nudix (nucleoside diphosphate linked moiety X)-type motif 19 |
chr2_+_105471969 | 9.48 |
ENST00000361360.2
|
POU3F3
|
POU class 3 homeobox 3 |
chr5_-_138725560 | 9.47 |
ENST00000412103.2
ENST00000457570.2 |
MZB1
|
marginal zone B and B1 cell-specific protein |
chr4_+_156588806 | 9.46 |
ENST00000513574.1
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr19_+_35521616 | 9.46 |
ENST00000595652.1
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
chr5_-_138725594 | 9.41 |
ENST00000302125.8
|
MZB1
|
marginal zone B and B1 cell-specific protein |
chr8_+_144816303 | 9.40 |
ENST00000533004.1
|
FAM83H-AS1
|
FAM83H antisense RNA 1 (head to head) |
chr19_-_50432711 | 9.40 |
ENST00000597723.1
ENST00000599788.1 ENST00000596217.1 ENST00000593652.1 ENST00000599567.1 ENST00000600935.1 ENST00000596011.1 ENST00000596022.1 ENST00000597295.1 |
NUP62
IL4I1
|
nucleoporin 62kDa interleukin 4 induced 1 |
chr1_+_12227035 | 9.32 |
ENST00000376259.3
ENST00000536782.1 |
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B |
chr1_+_11866270 | 9.31 |
ENST00000376497.3
ENST00000376487.3 ENST00000376496.3 |
CLCN6
|
chloride channel, voltage-sensitive 6 |
chr1_+_22962948 | 9.28 |
ENST00000374642.3
|
C1QA
|
complement component 1, q subcomponent, A chain |
chr10_-_73611046 | 9.22 |
ENST00000394934.1
ENST00000394936.3 |
PSAP
|
prosaposin |
chr17_+_80693427 | 9.21 |
ENST00000300784.7
|
FN3K
|
fructosamine 3 kinase |
chr5_-_179285848 | 9.18 |
ENST00000403396.2
ENST00000292586.6 |
C5orf45
|
chromosome 5 open reading frame 45 |
chr6_+_31554962 | 9.13 |
ENST00000376092.3
ENST00000376086.3 ENST00000303757.8 ENST00000376093.2 ENST00000376102.3 |
LST1
|
leukocyte specific transcript 1 |
chr1_+_14075865 | 9.09 |
ENST00000413440.1
|
PRDM2
|
PR domain containing 2, with ZNF domain |
chr20_-_39317868 | 9.02 |
ENST00000373313.2
|
MAFB
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B |
chr6_-_32731243 | 8.97 |
ENST00000427449.1
ENST00000411527.1 |
HLA-DQB2
|
major histocompatibility complex, class II, DQ beta 2 |
chr2_+_90259593 | 8.96 |
ENST00000471857.1
|
IGKV1D-8
|
immunoglobulin kappa variable 1D-8 |
chr3_+_101568349 | 8.94 |
ENST00000326151.5
ENST00000326172.5 |
NFKBIZ
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta |
chr19_+_42381173 | 8.93 |
ENST00000221972.3
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
chr5_+_56111361 | 8.89 |
ENST00000399503.3
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase |
chr11_-_615570 | 8.80 |
ENST00000525445.1
ENST00000348655.6 ENST00000397566.1 |
IRF7
|
interferon regulatory factor 7 |
chr7_+_80275752 | 8.76 |
ENST00000419819.2
|
CD36
|
CD36 molecule (thrombospondin receptor) |
chr17_+_7239821 | 8.76 |
ENST00000158762.3
ENST00000570457.2 |
ACAP1
|
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
chr5_-_115910630 | 8.75 |
ENST00000343348.6
|
SEMA6A
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
chr3_+_10206545 | 8.72 |
ENST00000256458.4
|
IRAK2
|
interleukin-1 receptor-associated kinase 2 |
chr1_-_11866034 | 8.71 |
ENST00000376590.3
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H) |
chr20_-_18774614 | 8.71 |
ENST00000412553.1
|
LINC00652
|
long intergenic non-protein coding RNA 652 |
chr12_+_6561190 | 8.70 |
ENST00000544021.1
ENST00000266556.7 |
TAPBPL
|
TAP binding protein-like |
chr19_+_49838653 | 8.68 |
ENST00000598095.1
ENST00000426897.2 ENST00000323906.4 ENST00000535669.2 ENST00000597602.1 ENST00000595660.1 |
CD37
|
CD37 molecule |
chr19_-_11591848 | 8.66 |
ENST00000359227.3
|
ELAVL3
|
ELAV like neuron-specific RNA binding protein 3 |
chr11_+_44587141 | 8.65 |
ENST00000227155.4
ENST00000342935.3 ENST00000532544.1 |
CD82
|
CD82 molecule |
chr17_+_34639793 | 8.51 |
ENST00000394465.2
ENST00000394463.2 ENST00000378342.4 |
CCL4L2
|
chemokine (C-C motif) ligand 4-like 2 |
chr9_+_129677039 | 8.49 |
ENST00000259351.5
ENST00000424082.2 ENST00000394022.3 ENST00000394011.3 ENST00000319107.4 |
RALGPS1
|
Ral GEF with PH domain and SH3 binding motif 1 |
chr20_+_62369623 | 8.45 |
ENST00000467211.1
|
RP4-583P15.14
|
RP4-583P15.14 |
chr14_-_106805716 | 8.45 |
ENST00000438142.2
|
IGHV4-31
|
immunoglobulin heavy variable 4-31 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
29.2 | 87.7 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
26.5 | 79.6 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
6.9 | 20.8 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
6.7 | 20.2 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
6.1 | 18.2 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
5.8 | 23.3 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
5.7 | 45.6 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
5.6 | 39.2 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
5.6 | 16.7 | GO:1904897 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
5.4 | 5.4 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
5.4 | 16.2 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
5.2 | 20.7 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
4.9 | 29.2 | GO:0010193 | response to ozone(GO:0010193) |
4.9 | 14.6 | GO:0021571 | rhombomere 5 development(GO:0021571) |
4.8 | 19.2 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
4.7 | 37.9 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
4.7 | 4.7 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
4.6 | 18.3 | GO:0071461 | cellular response to redox state(GO:0071461) |
4.6 | 13.7 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
4.6 | 13.7 | GO:1900369 | transcription, RNA-templated(GO:0001172) regulation of RNA interference(GO:1900368) negative regulation of RNA interference(GO:1900369) positive regulation of protein localization to nucleolus(GO:1904751) |
4.5 | 18.2 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
4.5 | 13.6 | GO:1990523 | negative regulation of neuromuscular junction development(GO:1904397) bone regeneration(GO:1990523) |
4.5 | 18.0 | GO:2001187 | actin polymerization-dependent cell motility(GO:0070358) positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
4.4 | 13.3 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
4.4 | 13.3 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
4.2 | 12.7 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
4.2 | 4.2 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
4.2 | 12.6 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
4.2 | 16.6 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
4.1 | 32.9 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
3.9 | 27.6 | GO:0072564 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
3.8 | 11.5 | GO:1900159 | iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) positive regulation of bone mineralization involved in bone maturation(GO:1900159) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
3.8 | 3.8 | GO:2000410 | regulation of thymocyte migration(GO:2000410) |
3.8 | 247.7 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
3.8 | 18.9 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
3.8 | 22.5 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
3.8 | 7.5 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
3.8 | 22.5 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
3.7 | 15.0 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
3.7 | 18.6 | GO:0015670 | carbon dioxide transport(GO:0015670) |
3.7 | 14.8 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
3.7 | 11.1 | GO:1904404 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
3.7 | 11.0 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
3.5 | 3.5 | GO:1902994 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
3.4 | 3.4 | GO:0060433 | bronchus development(GO:0060433) |
3.4 | 10.1 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) |
3.3 | 39.2 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
3.3 | 26.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
3.3 | 3.3 | GO:0055073 | cadmium ion homeostasis(GO:0055073) |
3.2 | 9.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
3.2 | 12.6 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
3.1 | 12.4 | GO:0015917 | aminophospholipid transport(GO:0015917) |
3.1 | 12.2 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
2.9 | 11.7 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
2.9 | 11.6 | GO:2000768 | glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
2.9 | 8.7 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
2.8 | 19.9 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
2.8 | 16.9 | GO:0070560 | protein secretion by platelet(GO:0070560) |
2.7 | 2.7 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
2.6 | 7.9 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
2.6 | 7.9 | GO:1901731 | positive regulation of platelet aggregation(GO:1901731) |
2.6 | 13.1 | GO:0000429 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
2.6 | 5.3 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
2.6 | 7.7 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
2.6 | 46.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
2.5 | 252.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
2.5 | 12.4 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
2.5 | 7.4 | GO:0050960 | detection of temperature stimulus involved in thermoception(GO:0050960) response to capsazepine(GO:1901594) |
2.4 | 4.9 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
2.4 | 14.6 | GO:0006857 | oligopeptide transport(GO:0006857) |
2.4 | 7.2 | GO:0051037 | histone displacement(GO:0001207) regulation of transcription involved in meiotic cell cycle(GO:0051037) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
2.4 | 7.1 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
2.4 | 9.4 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
2.3 | 21.0 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
2.3 | 4.7 | GO:0019086 | late viral transcription(GO:0019086) |
2.3 | 6.8 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
2.2 | 11.1 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
2.2 | 8.9 | GO:0060023 | soft palate development(GO:0060023) |
2.2 | 6.5 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
2.1 | 10.7 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
2.1 | 6.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
2.1 | 6.3 | GO:0035565 | regulation of pronephros size(GO:0035565) renal glucose absorption(GO:0035623) |
2.1 | 4.2 | GO:1902809 | skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
2.1 | 16.7 | GO:0006013 | mannose metabolic process(GO:0006013) |
2.1 | 10.4 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
2.1 | 6.2 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
2.0 | 4.1 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
2.0 | 2.0 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
2.0 | 24.5 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
2.0 | 12.0 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
2.0 | 4.0 | GO:0061056 | sclerotome development(GO:0061056) |
2.0 | 3.9 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
2.0 | 7.8 | GO:1903936 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
2.0 | 7.8 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
1.9 | 5.8 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
1.9 | 7.6 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
1.9 | 5.7 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
1.9 | 7.5 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
1.9 | 22.5 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) |
1.9 | 9.3 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
1.9 | 16.7 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
1.8 | 5.5 | GO:1903413 | cellular response to bile acid(GO:1903413) |
1.8 | 7.3 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
1.8 | 29.1 | GO:0051255 | spindle midzone assembly(GO:0051255) |
1.8 | 20.0 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
1.8 | 5.4 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) galactose catabolic process via UDP-galactose(GO:0033499) |
1.8 | 1.8 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
1.8 | 3.6 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
1.8 | 17.9 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
1.8 | 7.1 | GO:0009386 | translational attenuation(GO:0009386) |
1.8 | 278.4 | GO:0002377 | immunoglobulin production(GO:0002377) |
1.8 | 19.6 | GO:0006600 | creatine metabolic process(GO:0006600) |
1.8 | 1.8 | GO:0071361 | cellular response to ethanol(GO:0071361) |
1.8 | 5.3 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
1.8 | 8.8 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
1.7 | 5.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
1.7 | 8.7 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
1.7 | 8.6 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
1.7 | 5.2 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
1.7 | 3.4 | GO:0071156 | regulation of cell cycle arrest(GO:0071156) |
1.7 | 8.5 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
1.7 | 5.1 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
1.7 | 15.3 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
1.7 | 20.3 | GO:0006657 | CDP-choline pathway(GO:0006657) |
1.7 | 5.0 | GO:0098759 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
1.7 | 5.0 | GO:0021718 | pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
1.7 | 5.0 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
1.7 | 34.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.7 | 5.0 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.6 | 9.9 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
1.6 | 8.2 | GO:0048478 | replication fork protection(GO:0048478) |
1.6 | 6.6 | GO:0015793 | glycerol transport(GO:0015793) |
1.6 | 13.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
1.6 | 9.7 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
1.6 | 6.5 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
1.6 | 8.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
1.6 | 7.9 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
1.6 | 34.7 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
1.6 | 9.5 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
1.6 | 4.7 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
1.6 | 4.7 | GO:0021633 | optic nerve structural organization(GO:0021633) |
1.6 | 17.1 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
1.6 | 4.7 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
1.5 | 4.6 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
1.5 | 10.8 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
1.5 | 4.6 | GO:0090034 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
1.5 | 3.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
1.5 | 6.1 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
1.5 | 3.0 | GO:0035112 | genitalia morphogenesis(GO:0035112) |
1.5 | 4.5 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
1.5 | 94.9 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
1.5 | 11.7 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
1.5 | 21.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
1.5 | 5.8 | GO:0001743 | optic placode formation(GO:0001743) axial mesoderm morphogenesis(GO:0048319) beta-catenin destruction complex assembly(GO:1904885) |
1.5 | 7.3 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
1.4 | 4.3 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
1.4 | 5.8 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
1.4 | 5.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.4 | 4.3 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
1.4 | 2.8 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
1.4 | 12.6 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
1.4 | 4.2 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
1.4 | 4.2 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
1.4 | 8.3 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
1.4 | 13.8 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
1.4 | 34.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
1.4 | 4.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
1.4 | 13.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
1.4 | 4.1 | GO:0002677 | negative regulation of chronic inflammatory response(GO:0002677) negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
1.3 | 9.4 | GO:0098704 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
1.3 | 2.7 | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation(GO:0050731) |
1.3 | 9.3 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
1.3 | 5.3 | GO:0003335 | corneocyte development(GO:0003335) |
1.3 | 11.9 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
1.3 | 3.9 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
1.3 | 2.6 | GO:0014055 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
1.3 | 2.6 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
1.3 | 2.5 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
1.2 | 13.7 | GO:0032364 | oxygen homeostasis(GO:0032364) |
1.2 | 3.7 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
1.2 | 6.1 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
1.2 | 3.7 | GO:2000724 | nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
1.2 | 6.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
1.2 | 2.4 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
1.2 | 9.7 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
1.2 | 9.6 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
1.2 | 7.2 | GO:0051012 | microtubule sliding(GO:0051012) |
1.2 | 14.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.2 | 7.1 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
1.2 | 4.8 | GO:0032899 | regulation of neurotrophin production(GO:0032899) |
1.2 | 5.9 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
1.2 | 16.4 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
1.2 | 7.0 | GO:0050807 | regulation of synapse organization(GO:0050807) |
1.2 | 5.8 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
1.1 | 3.4 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
1.1 | 1.1 | GO:0034135 | regulation of toll-like receptor 2 signaling pathway(GO:0034135) positive regulation of toll-like receptor 2 signaling pathway(GO:0034137) |
1.1 | 11.3 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
1.1 | 3.4 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
1.1 | 1.1 | GO:0003383 | apical constriction(GO:0003383) |
1.1 | 5.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.1 | 6.7 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
1.1 | 5.5 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
1.1 | 9.9 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
1.1 | 4.4 | GO:1904995 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
1.1 | 5.4 | GO:0032494 | response to peptidoglycan(GO:0032494) |
1.1 | 2.2 | GO:0016540 | protein autoprocessing(GO:0016540) |
1.1 | 5.4 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
1.1 | 13.9 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
1.1 | 4.3 | GO:1904207 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) positive regulation of metalloendopeptidase activity(GO:1904685) |
1.1 | 3.2 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
1.1 | 3.2 | GO:1903027 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
1.0 | 4.1 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
1.0 | 3.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
1.0 | 3.1 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
1.0 | 1.0 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
1.0 | 3.1 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
1.0 | 8.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
1.0 | 4.1 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
1.0 | 4.1 | GO:0097368 | histone H4-K20 trimethylation(GO:0034773) establishment of Sertoli cell barrier(GO:0097368) |
1.0 | 4.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
1.0 | 15.3 | GO:0008340 | determination of adult lifespan(GO:0008340) |
1.0 | 11.2 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
1.0 | 5.0 | GO:1904996 | PML body organization(GO:0030578) positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
1.0 | 2.0 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
1.0 | 8.0 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
1.0 | 4.0 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
1.0 | 5.0 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
1.0 | 2.9 | GO:1900138 | negative regulation of icosanoid secretion(GO:0032304) oxidative stress-induced premature senescence(GO:0090403) negative regulation of phospholipase A2 activity(GO:1900138) |
1.0 | 2.9 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
1.0 | 1.0 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
1.0 | 2.9 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.9 | 15.1 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.9 | 2.8 | GO:0032456 | endocytic recycling(GO:0032456) |
0.9 | 11.2 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.9 | 2.8 | GO:0048852 | hypophysis morphogenesis(GO:0048850) diencephalon morphogenesis(GO:0048852) |
0.9 | 0.9 | GO:0032423 | regulation of mismatch repair(GO:0032423) positive regulation of mismatch repair(GO:0032425) |
0.9 | 4.7 | GO:0015744 | succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
0.9 | 3.7 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.9 | 1.8 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
0.9 | 12.8 | GO:0051014 | actin filament severing(GO:0051014) |
0.9 | 5.5 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.9 | 7.3 | GO:0090257 | regulation of muscle system process(GO:0090257) |
0.9 | 7.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.9 | 5.4 | GO:0009450 | gamma-aminobutyric acid catabolic process(GO:0009450) |
0.9 | 3.6 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.9 | 5.3 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.9 | 1.8 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.9 | 15.9 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.9 | 7.9 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.9 | 12.3 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.9 | 1.7 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
0.9 | 1.7 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.9 | 3.4 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
0.9 | 7.7 | GO:0032781 | positive regulation of ATPase activity(GO:0032781) |
0.9 | 2.6 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
0.8 | 3.4 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.8 | 5.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.8 | 3.3 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.8 | 3.3 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.8 | 7.4 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.8 | 23.0 | GO:0045730 | respiratory burst(GO:0045730) |
0.8 | 2.5 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.8 | 1.6 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.8 | 2.4 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.8 | 2.4 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
0.8 | 12.8 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.8 | 3.2 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
0.8 | 7.2 | GO:0015889 | cobalamin transport(GO:0015889) |
0.8 | 19.8 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.8 | 14.1 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.8 | 3.9 | GO:0033080 | immature T cell proliferation in thymus(GO:0033080) |
0.8 | 5.4 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.8 | 12.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.8 | 1.5 | GO:0032571 | response to vitamin K(GO:0032571) |
0.8 | 1.5 | GO:0061010 | gall bladder development(GO:0061010) |
0.8 | 12.2 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.8 | 3.1 | GO:0061743 | motor learning(GO:0061743) |
0.8 | 6.9 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.8 | 4.6 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.8 | 1.5 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.8 | 1.5 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.8 | 4.5 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.8 | 3.8 | GO:0043382 | regulation of memory T cell differentiation(GO:0043380) positive regulation of memory T cell differentiation(GO:0043382) positive regulation of T-helper 17 cell differentiation(GO:2000321) positive regulation of T-helper 17 cell lineage commitment(GO:2000330) |
0.8 | 4.5 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.7 | 2.2 | GO:0019605 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
0.7 | 2.9 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) |
0.7 | 1.5 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
0.7 | 20.4 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.7 | 13.1 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.7 | 1.4 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.7 | 3.6 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.7 | 4.3 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.7 | 2.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.7 | 2.2 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.7 | 2.9 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.7 | 1.4 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.7 | 27.1 | GO:0045576 | mast cell activation(GO:0045576) |
0.7 | 3.6 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.7 | 3.6 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.7 | 2.1 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.7 | 5.7 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.7 | 2.1 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.7 | 2.8 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.7 | 15.5 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.7 | 3.5 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
0.7 | 3.5 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.7 | 5.6 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.7 | 1.4 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.7 | 1.4 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
0.7 | 5.5 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.7 | 2.1 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.7 | 8.9 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.7 | 4.8 | GO:0002027 | regulation of heart rate(GO:0002027) |
0.7 | 2.0 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.7 | 6.8 | GO:0048535 | lymph node development(GO:0048535) |
0.7 | 2.7 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.7 | 2.7 | GO:0061370 | response to luteinizing hormone(GO:0034699) testosterone biosynthetic process(GO:0061370) cellular response to luteinizing hormone stimulus(GO:0071373) |
0.7 | 8.1 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.7 | 2.7 | GO:0042426 | choline catabolic process(GO:0042426) |
0.7 | 8.7 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.7 | 5.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.7 | 10.6 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.7 | 12.5 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.7 | 2.6 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.7 | 5.2 | GO:0015705 | iodide transport(GO:0015705) |
0.6 | 5.8 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.6 | 2.6 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.6 | 6.4 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.6 | 1.9 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
0.6 | 5.1 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.6 | 2.5 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.6 | 4.9 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.6 | 2.5 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.6 | 1.8 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.6 | 14.7 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.6 | 1.2 | GO:0002384 | hepatic immune response(GO:0002384) |
0.6 | 6.6 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.6 | 1.8 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
0.6 | 3.6 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.6 | 3.0 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.6 | 1.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.6 | 1.2 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.6 | 18.3 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.6 | 0.6 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
0.6 | 1.2 | GO:0032759 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
0.6 | 1.7 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.6 | 9.9 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.6 | 5.2 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.6 | 8.6 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.6 | 1.7 | GO:0048073 | regulation of eye pigmentation(GO:0048073) positive regulation of eye pigmentation(GO:0048075) |
0.6 | 1.7 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.6 | 15.3 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.6 | 2.2 | GO:0007525 | somatic muscle development(GO:0007525) |
0.6 | 1.7 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.6 | 2.2 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.6 | 5.5 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.5 | 8.2 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.5 | 3.3 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.5 | 2.2 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.5 | 3.3 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.5 | 3.8 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.5 | 0.5 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.5 | 9.2 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.5 | 1.6 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.5 | 1.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.5 | 1.6 | GO:0097178 | ruffle assembly(GO:0097178) |
0.5 | 2.7 | GO:0007140 | male meiosis(GO:0007140) |
0.5 | 7.0 | GO:0060538 | skeletal muscle organ development(GO:0060538) |
0.5 | 1.6 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.5 | 1.1 | GO:0001757 | somite specification(GO:0001757) |
0.5 | 0.5 | GO:0033079 | immature T cell proliferation(GO:0033079) |
0.5 | 17.2 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.5 | 3.1 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.5 | 2.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.5 | 4.7 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.5 | 1.0 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.5 | 3.1 | GO:0015811 | L-cystine transport(GO:0015811) |
0.5 | 3.1 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.5 | 1.5 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.5 | 3.6 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.5 | 10.0 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.5 | 1.0 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.5 | 1.5 | GO:0015855 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
0.5 | 1.5 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.5 | 12.4 | GO:0006825 | copper ion transport(GO:0006825) |
0.5 | 3.0 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.5 | 5.9 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.5 | 2.5 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.5 | 3.4 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.5 | 1.5 | GO:0072312 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
0.5 | 7.8 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.5 | 1.0 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.5 | 3.9 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.5 | 6.3 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.5 | 2.4 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.5 | 5.7 | GO:0098780 | macromitophagy(GO:0000423) response to mitochondrial depolarisation(GO:0098780) |
0.5 | 2.8 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.5 | 3.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.5 | 1.9 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.5 | 2.3 | GO:0031333 | negative regulation of protein complex assembly(GO:0031333) |
0.5 | 1.9 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.5 | 3.2 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.5 | 2.3 | GO:0090191 | negative regulation of mesonephros development(GO:0061218) negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.5 | 3.7 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.5 | 2.7 | GO:0070458 | cellular detoxification of nitrogen compound(GO:0070458) |
0.5 | 0.9 | GO:0045682 | regulation of keratinocyte differentiation(GO:0045616) regulation of epidermis development(GO:0045682) |
0.5 | 7.7 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.4 | 5.4 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.4 | 1.8 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.4 | 0.4 | GO:0045650 | negative regulation of B cell differentiation(GO:0045578) negative regulation of macrophage differentiation(GO:0045650) |
0.4 | 2.6 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.4 | 2.6 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.4 | 1.7 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.4 | 2.6 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.4 | 1.3 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.4 | 2.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.4 | 1.7 | GO:1905229 | cellular response to glycoprotein(GO:1904588) cellular response to thyrotropin-releasing hormone(GO:1905229) |
0.4 | 2.5 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.4 | 1.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.4 | 3.3 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.4 | 6.7 | GO:0045187 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.4 | 4.2 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.4 | 2.9 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.4 | 2.1 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.4 | 6.2 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.4 | 6.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.4 | 7.0 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.4 | 7.3 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.4 | 2.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.4 | 4.0 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.4 | 1.2 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.4 | 8.1 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.4 | 1.6 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
0.4 | 1.6 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.4 | 0.8 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.4 | 7.5 | GO:0003341 | cilium movement(GO:0003341) |
0.4 | 2.0 | GO:0099624 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.4 | 1.2 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) |
0.4 | 3.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.4 | 1.6 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.4 | 16.3 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.4 | 3.1 | GO:0070633 | transepithelial transport(GO:0070633) |
0.4 | 1.5 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.4 | 1.5 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.4 | 1.1 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.4 | 0.4 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
0.4 | 2.3 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.4 | 5.6 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.4 | 12.8 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.4 | 2.6 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.4 | 0.7 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.4 | 5.6 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.4 | 1.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.4 | 1.5 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.4 | 0.4 | GO:0042220 | response to cocaine(GO:0042220) |
0.4 | 0.4 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) renal protein absorption(GO:0097017) renal albumin absorption(GO:0097018) oligodendrocyte apoptotic process(GO:0097252) regulation of renal albumin absorption(GO:2000532) |
0.4 | 2.6 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
0.4 | 2.6 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.4 | 2.6 | GO:0038129 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) ERBB3 signaling pathway(GO:0038129) |
0.4 | 1.5 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.4 | 1.8 | GO:1900020 | embryonic genitalia morphogenesis(GO:0030538) regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.4 | 3.6 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.4 | 7.6 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.4 | 2.2 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.4 | 1.1 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.4 | 1.4 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.4 | 6.5 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.4 | 1.1 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.4 | 5.7 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.4 | 1.1 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.4 | 1.1 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.3 | 1.4 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.3 | 2.8 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.3 | 0.7 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.3 | 5.2 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.3 | 4.2 | GO:0036065 | fucosylation(GO:0036065) |
0.3 | 4.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.3 | 2.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.3 | 2.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.3 | 4.4 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.3 | 2.3 | GO:0031112 | positive regulation of microtubule polymerization or depolymerization(GO:0031112) |
0.3 | 3.0 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.3 | 17.4 | GO:0050672 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
0.3 | 3.9 | GO:0001945 | lymph vessel development(GO:0001945) |
0.3 | 2.6 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.3 | 5.1 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.3 | 2.6 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.3 | 3.8 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.3 | 1.6 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.3 | 2.5 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.3 | 2.8 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.3 | 16.6 | GO:0016266 | O-glycan processing(GO:0016266) |
0.3 | 5.0 | GO:0021854 | hypothalamus development(GO:0021854) |
0.3 | 1.9 | GO:0001573 | ganglioside metabolic process(GO:0001573) ganglioside catabolic process(GO:0006689) |
0.3 | 2.5 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.3 | 0.9 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.3 | 1.8 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.3 | 3.4 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.3 | 4.6 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.3 | 4.0 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.3 | 3.6 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.3 | 0.6 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.3 | 4.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.3 | 1.5 | GO:0060579 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.3 | 2.7 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.3 | 0.6 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.3 | 4.2 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.3 | 2.1 | GO:0042730 | fibrinolysis(GO:0042730) |
0.3 | 4.1 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.3 | 2.4 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.3 | 1.2 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.3 | 0.6 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.3 | 0.3 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.3 | 1.7 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.3 | 4.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.3 | 2.6 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.3 | 5.8 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.3 | 7.8 | GO:0050779 | RNA destabilization(GO:0050779) |
0.3 | 1.4 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.3 | 2.6 | GO:1901216 | positive regulation of neuron death(GO:1901216) |
0.3 | 0.6 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.3 | 2.8 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.3 | 0.6 | GO:0008050 | female courtship behavior(GO:0008050) |
0.3 | 5.3 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.3 | 1.4 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.3 | 0.8 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
0.3 | 5.3 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.3 | 0.6 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.3 | 2.5 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.3 | 1.9 | GO:0006477 | protein sulfation(GO:0006477) |
0.3 | 5.2 | GO:0045954 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.3 | 0.8 | GO:0097359 | UDP-glucosylation(GO:0097359) |
0.3 | 0.5 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.3 | 6.8 | GO:0032731 | positive regulation of interleukin-1 beta production(GO:0032731) |
0.3 | 3.0 | GO:0051601 | exocyst localization(GO:0051601) |
0.3 | 3.5 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.3 | 1.9 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.3 | 1.9 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.3 | 2.4 | GO:0051026 | chiasma assembly(GO:0051026) |
0.3 | 2.4 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.3 | 2.4 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.3 | 2.6 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.3 | 2.3 | GO:0006554 | lysine catabolic process(GO:0006554) |
0.3 | 1.5 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.3 | 0.8 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
0.3 | 1.3 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.3 | 2.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.3 | 4.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.2 | 4.2 | GO:0046425 | regulation of JAK-STAT cascade(GO:0046425) regulation of STAT cascade(GO:1904892) |
0.2 | 1.5 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.2 | 0.7 | GO:0070541 | response to platinum ion(GO:0070541) |
0.2 | 1.2 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
0.2 | 4.6 | GO:0033198 | response to ATP(GO:0033198) |
0.2 | 1.7 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.2 | 6.6 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.2 | 1.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.2 | 4.6 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.2 | 0.7 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.2 | 2.1 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
0.2 | 0.5 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.2 | 1.0 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.2 | 0.9 | GO:0015992 | hydrogen transport(GO:0006818) proton transport(GO:0015992) |
0.2 | 1.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.2 | 2.6 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 | 7.5 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.2 | 0.5 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.2 | 1.4 | GO:0086070 | SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.2 | 2.1 | GO:0001502 | cartilage condensation(GO:0001502) |
0.2 | 0.7 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
0.2 | 0.2 | GO:0042756 | drinking behavior(GO:0042756) |
0.2 | 4.8 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.2 | 11.2 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 0.7 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.2 | 7.7 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) |
0.2 | 0.7 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.2 | 4.0 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.2 | 6.9 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.2 | 5.1 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 2.9 | GO:0021756 | striatum development(GO:0021756) |
0.2 | 2.6 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.2 | 7.5 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.2 | 5.5 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 0.7 | GO:0001820 | serotonin secretion(GO:0001820) |
0.2 | 0.9 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.2 | 3.9 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.2 | 1.5 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.2 | 3.0 | GO:0007340 | acrosome reaction(GO:0007340) |
0.2 | 0.6 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.2 | 2.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.2 | 10.6 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.2 | 3.5 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.2 | 1.1 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
0.2 | 1.5 | GO:1901070 | guanosine-containing compound biosynthetic process(GO:1901070) |
0.2 | 6.8 | GO:0014823 | response to activity(GO:0014823) |
0.2 | 1.7 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 4.1 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 2.1 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 1.2 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.2 | 3.9 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 2.0 | GO:0044241 | lipid digestion(GO:0044241) |
0.2 | 1.4 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.2 | 3.0 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.2 | 1.6 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.2 | 1.2 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.2 | 0.8 | GO:0051918 | regulation of fibrinolysis(GO:0051917) negative regulation of fibrinolysis(GO:0051918) |
0.2 | 0.6 | GO:0009304 | tRNA transcription(GO:0009304) 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.2 | 2.8 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.2 | 3.0 | GO:0022038 | corpus callosum development(GO:0022038) |
0.2 | 1.6 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.2 | 2.4 | GO:0015884 | folic acid transport(GO:0015884) |
0.2 | 1.2 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) arterial endothelial cell differentiation(GO:0060842) |
0.2 | 1.6 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.2 | 0.4 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
0.2 | 1.2 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.2 | 3.5 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 4.7 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.2 | 0.6 | GO:0032308 | regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
0.2 | 0.9 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.2 | 1.6 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.2 | 0.7 | GO:2000551 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) regulation of T-helper 2 cell cytokine production(GO:2000551) positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.2 | 3.3 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.2 | 1.4 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.2 | 1.3 | GO:1903513 | endoplasmic reticulum to cytosol transport(GO:1903513) |
0.2 | 2.9 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.2 | 3.8 | GO:0002076 | osteoblast development(GO:0002076) |
0.2 | 1.1 | GO:0002021 | response to dietary excess(GO:0002021) |
0.2 | 0.4 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.2 | 0.7 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.2 | 0.4 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.2 | 1.4 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.2 | 2.1 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.2 | 1.7 | GO:0000050 | urea cycle(GO:0000050) |
0.2 | 6.0 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.2 | 1.9 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.2 | 2.0 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 1.0 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.2 | 3.8 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.2 | 3.2 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.2 | 1.8 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 2.9 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.2 | 1.5 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.2 | 6.4 | GO:0016525 | negative regulation of angiogenesis(GO:0016525) |
0.2 | 1.6 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 0.5 | GO:0090659 | walking behavior(GO:0090659) |
0.2 | 1.3 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.2 | 3.3 | GO:0045777 | positive regulation of blood pressure(GO:0045777) |
0.2 | 4.1 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.2 | 9.0 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.2 | 0.8 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 1.1 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.2 | 1.4 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.2 | 11.0 | GO:0007188 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway(GO:0007188) |
0.2 | 1.9 | GO:0006972 | hyperosmotic response(GO:0006972) |
0.2 | 5.3 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.2 | 0.9 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.2 | 1.5 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
0.2 | 10.5 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.2 | 2.7 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.2 | 3.0 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.2 | 0.5 | GO:1990785 | response to water-immersion restraint stress(GO:1990785) |
0.1 | 1.3 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 1.0 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.1 | 3.9 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.1 | 1.3 | GO:0050709 | negative regulation of protein secretion(GO:0050709) |
0.1 | 2.6 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.1 | 1.0 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 8.5 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 5.4 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.1 | 0.8 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.1 | 3.6 | GO:0019228 | neuronal action potential(GO:0019228) |
0.1 | 1.6 | GO:0048333 | mesodermal cell differentiation(GO:0048333) |
0.1 | 1.0 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.1 | 0.6 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.1 | 3.7 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) |
0.1 | 3.4 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.1 | 0.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 1.3 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 1.8 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 0.7 | GO:0038061 | NIK/NF-kappaB signaling(GO:0038061) |
0.1 | 14.9 | GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) |
0.1 | 4.2 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.1 | 0.6 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.1 | 4.5 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 2.0 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.1 | 1.6 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 0.5 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 1.4 | GO:0046855 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 1.6 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.1 | 0.1 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
0.1 | 0.7 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 0.5 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.1 | 2.6 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.1 | 0.7 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.1 | 0.7 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 3.6 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.8 | GO:0010828 | positive regulation of glucose transport(GO:0010828) |
0.1 | 0.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.4 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 1.9 | GO:0009798 | axis specification(GO:0009798) |
0.1 | 2.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 2.0 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.5 | GO:0006531 | aspartate metabolic process(GO:0006531) |
0.1 | 0.1 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.1 | 0.2 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) cell-cell adhesion involved in gastrulation(GO:0070586) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.1 | 1.9 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 2.2 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.6 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 0.2 | GO:0036102 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
0.1 | 1.1 | GO:0035640 | exploration behavior(GO:0035640) |
0.1 | 0.8 | GO:0001707 | mesoderm formation(GO:0001707) |
0.1 | 1.0 | GO:0040014 | regulation of multicellular organism growth(GO:0040014) |
0.1 | 1.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 1.3 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 0.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 1.5 | GO:0048536 | spleen development(GO:0048536) |
0.1 | 0.2 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.1 | 2.4 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.3 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.1 | 1.6 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.1 | 1.5 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.1 | 6.1 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.1 | 0.7 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 1.8 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.1 | 0.3 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.1 | 1.4 | GO:0048662 | negative regulation of smooth muscle cell proliferation(GO:0048662) |
0.1 | 0.4 | GO:0045683 | negative regulation of epidermal cell differentiation(GO:0045605) negative regulation of keratinocyte differentiation(GO:0045617) negative regulation of epidermis development(GO:0045683) |
0.1 | 0.8 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 1.9 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 0.6 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.3 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.8 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.1 | 0.5 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.6 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 2.5 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.4 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.1 | 0.7 | GO:0034033 | coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.7 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.1 | 0.4 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 0.7 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 0.8 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.1 | 1.0 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 2.0 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.3 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.1 | 0.4 | GO:0007187 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger(GO:0007187) |
0.1 | 2.0 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.1 | 1.5 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.4 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.1 | 0.9 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 0.6 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.1 | 1.3 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 3.3 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.1 | 3.0 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 0.7 | GO:0019363 | nicotinamide nucleotide biosynthetic process(GO:0019359) pyridine nucleotide biosynthetic process(GO:0019363) |
0.1 | 0.1 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.1 | 2.5 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.1 | 1.3 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
0.1 | 0.9 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 0.5 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.2 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.1 | 1.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.4 | GO:0006475 | internal protein amino acid acetylation(GO:0006475) |
0.1 | 12.2 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.0 | 0.5 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.0 | 0.2 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.0 | 0.9 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.1 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
0.0 | 0.4 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.0 | 1.1 | GO:0006351 | transcription, DNA-templated(GO:0006351) nucleic acid-templated transcription(GO:0097659) |
0.0 | 1.7 | GO:0007498 | mesoderm development(GO:0007498) |
0.0 | 0.7 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.5 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.2 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) |
0.0 | 0.8 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.7 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.1 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.0 | 1.0 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 1.2 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.2 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.0 | 0.3 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.0 | 0.4 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.4 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.0 | 1.1 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.9 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.2 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.0 | 0.2 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.0 | 0.7 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.2 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.0 | 0.4 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.0 | 0.0 | GO:0045820 | negative regulation of nucleotide catabolic process(GO:0030812) negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.0 | 0.1 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.0 | 0.1 | GO:0021510 | spinal cord development(GO:0021510) |
0.0 | 0.1 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.0 | 0.1 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.6 | 48.0 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
7.4 | 7.4 | GO:0030686 | 90S preribosome(GO:0030686) |
5.2 | 36.6 | GO:0019815 | B cell receptor complex(GO:0019815) |
5.2 | 20.7 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
5.0 | 250.7 | GO:0042571 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
4.2 | 4.2 | GO:0043218 | compact myelin(GO:0043218) |
4.2 | 12.5 | GO:0020003 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
3.8 | 19.2 | GO:0005602 | complement component C1 complex(GO:0005602) |
3.4 | 37.9 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
3.4 | 13.7 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
3.3 | 26.7 | GO:0035976 | AP1 complex(GO:0035976) |
3.1 | 18.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
2.9 | 14.5 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
2.7 | 57.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
2.6 | 15.4 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
2.6 | 7.7 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
2.4 | 4.9 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
2.4 | 9.4 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
2.3 | 15.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
2.2 | 17.9 | GO:0032010 | phagolysosome(GO:0032010) |
2.1 | 6.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
2.1 | 4.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
2.1 | 8.2 | GO:0043596 | nuclear replication fork(GO:0043596) |
2.0 | 24.0 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
1.9 | 7.8 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
1.9 | 13.6 | GO:0097361 | CIA complex(GO:0097361) |
1.9 | 7.7 | GO:0070695 | FHF complex(GO:0070695) |
1.9 | 13.3 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
1.8 | 30.8 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
1.8 | 41.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.7 | 15.2 | GO:0070938 | contractile ring(GO:0070938) |
1.6 | 6.3 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
1.5 | 24.9 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.4 | 5.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
1.4 | 4.2 | GO:0036398 | TCR signalosome(GO:0036398) |
1.4 | 4.1 | GO:0001652 | granular component(GO:0001652) |
1.4 | 8.1 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
1.3 | 7.9 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.3 | 6.5 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
1.3 | 5.2 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
1.3 | 18.0 | GO:0031209 | SCAR complex(GO:0031209) |
1.3 | 5.1 | GO:0044194 | cytolytic granule(GO:0044194) |
1.3 | 3.8 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
1.3 | 5.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.2 | 4.9 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.2 | 6.0 | GO:0032021 | NELF complex(GO:0032021) |
1.2 | 4.6 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
1.2 | 3.5 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
1.1 | 9.0 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
1.1 | 11.2 | GO:0071953 | elastic fiber(GO:0071953) |
1.1 | 17.6 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.1 | 6.5 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
1.1 | 75.7 | GO:0015030 | Cajal body(GO:0015030) |
1.1 | 3.2 | GO:0031672 | A band(GO:0031672) |
1.1 | 37.0 | GO:0042629 | mast cell granule(GO:0042629) |
1.0 | 3.1 | GO:0005921 | gap junction(GO:0005921) |
1.0 | 8.2 | GO:0043196 | varicosity(GO:0043196) |
1.0 | 6.0 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
1.0 | 8.9 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.0 | 2.9 | GO:0002139 | stereocilia coupling link(GO:0002139) |
1.0 | 3.9 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
1.0 | 5.7 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.9 | 3.6 | GO:0031417 | NatC complex(GO:0031417) |
0.9 | 6.2 | GO:0001520 | outer dense fiber(GO:0001520) |
0.9 | 4.3 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.8 | 18.7 | GO:0000242 | pericentriolar material(GO:0000242) |
0.8 | 11.8 | GO:0033270 | paranode region of axon(GO:0033270) |
0.8 | 11.7 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.8 | 4.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.8 | 5.8 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.8 | 1.6 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.8 | 4.9 | GO:0000124 | SAGA complex(GO:0000124) |
0.8 | 3.3 | GO:0097449 | astrocyte projection(GO:0097449) |
0.8 | 4.0 | GO:0071546 | pi-body(GO:0071546) |
0.8 | 12.8 | GO:0032059 | bleb(GO:0032059) |
0.8 | 7.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.8 | 3.2 | GO:1990745 | EARP complex(GO:1990745) |
0.8 | 5.5 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.8 | 3.9 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.8 | 16.3 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.8 | 19.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.7 | 19.3 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.7 | 4.4 | GO:0070545 | PeBoW complex(GO:0070545) |
0.7 | 2.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.7 | 4.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.7 | 10.5 | GO:0031045 | dense core granule(GO:0031045) |
0.7 | 14.0 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.7 | 19.5 | GO:0005902 | microvillus(GO:0005902) |
0.7 | 2.7 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.7 | 4.1 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.7 | 3.4 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.7 | 24.8 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.7 | 4.7 | GO:0033010 | paranodal junction(GO:0033010) |
0.7 | 4.6 | GO:1990635 | proximal dendrite(GO:1990635) |
0.6 | 3.9 | GO:0002177 | manchette(GO:0002177) |
0.6 | 4.4 | GO:0097427 | microtubule bundle(GO:0097427) |
0.6 | 8.6 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.6 | 1.2 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.6 | 12.1 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.6 | 3.6 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.6 | 5.8 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.6 | 9.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.6 | 2.9 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.6 | 4.0 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.6 | 1.1 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.6 | 19.3 | GO:0051233 | spindle midzone(GO:0051233) |
0.6 | 4.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.6 | 6.2 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.6 | 16.8 | GO:0016459 | myosin complex(GO:0016459) |
0.5 | 1.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.5 | 2.7 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.5 | 9.6 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.5 | 12.5 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.5 | 5.5 | GO:0005883 | neurofilament(GO:0005883) |
0.5 | 5.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.5 | 1.5 | GO:0002079 | inner acrosomal membrane(GO:0002079) outer acrosomal membrane(GO:0002081) |
0.5 | 3.0 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.5 | 5.3 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.5 | 2.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.5 | 2.4 | GO:0070847 | core mediator complex(GO:0070847) |
0.5 | 2.4 | GO:0000801 | central element(GO:0000801) |
0.5 | 4.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.5 | 30.2 | GO:0031526 | brush border membrane(GO:0031526) |
0.5 | 4.1 | GO:0032039 | integrator complex(GO:0032039) |
0.5 | 1.8 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.4 | 4.9 | GO:0005642 | annulate lamellae(GO:0005642) |
0.4 | 13.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.4 | 2.6 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.4 | 75.6 | GO:0072562 | blood microparticle(GO:0072562) |
0.4 | 21.0 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.4 | 1.7 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.4 | 7.9 | GO:0030673 | axolemma(GO:0030673) |
0.4 | 6.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.4 | 1.6 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.4 | 4.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.4 | 17.5 | GO:0030426 | growth cone(GO:0030426) |
0.4 | 9.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.4 | 4.4 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.4 | 2.4 | GO:0030175 | filopodium(GO:0030175) |
0.4 | 2.8 | GO:0032584 | growth cone membrane(GO:0032584) |
0.4 | 7.8 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.4 | 2.0 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.4 | 5.0 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.4 | 19.9 | GO:0016235 | aggresome(GO:0016235) |
0.4 | 1.1 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.4 | 1.5 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.4 | 1.1 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.4 | 8.3 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.4 | 1.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.4 | 3.4 | GO:0043194 | axon initial segment(GO:0043194) |
0.4 | 16.7 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.4 | 2.9 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.3 | 38.1 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.3 | 0.3 | GO:0000791 | euchromatin(GO:0000791) |
0.3 | 7.5 | GO:0030133 | transport vesicle(GO:0030133) |
0.3 | 2.7 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.3 | 2.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.3 | 1.0 | GO:0071159 | NF-kappaB complex(GO:0071159) |
0.3 | 3.9 | GO:0000800 | lateral element(GO:0000800) |
0.3 | 5.5 | GO:0030018 | Z disc(GO:0030018) I band(GO:0031674) |
0.3 | 27.4 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.3 | 2.5 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.3 | 5.3 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.3 | 3.7 | GO:0098636 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.3 | 1.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 6.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.3 | 4.5 | GO:0031527 | filopodium membrane(GO:0031527) |
0.3 | 3.8 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.3 | 4.1 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.3 | 1.7 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
0.3 | 3.6 | GO:0071437 | invadopodium(GO:0071437) |
0.3 | 3.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.3 | 1.9 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.3 | 4.9 | GO:0005861 | troponin complex(GO:0005861) |
0.3 | 1.9 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 1.6 | GO:1990037 | Lewy body core(GO:1990037) |
0.3 | 3.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.3 | 31.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 4.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.3 | 1.3 | GO:0072686 | mitotic spindle(GO:0072686) |
0.3 | 4.6 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 2.0 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.2 | 2.5 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.2 | 1.4 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.2 | 0.7 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
0.2 | 1.9 | GO:0043235 | receptor complex(GO:0043235) |
0.2 | 2.7 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 7.5 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.2 | 12.8 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 1.1 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.2 | 2.9 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 29.2 | GO:0005813 | centrosome(GO:0005813) |
0.2 | 20.8 | GO:0005814 | centriole(GO:0005814) |
0.2 | 2.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 1.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.2 | 0.6 | GO:0031905 | early endosome lumen(GO:0031905) |
0.2 | 3.0 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 1.7 | GO:0005694 | chromosome(GO:0005694) |
0.2 | 8.3 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 1.1 | GO:0008278 | cohesin complex(GO:0008278) |
0.2 | 2.5 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 2.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 13.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 6.2 | GO:0036064 | ciliary basal body(GO:0036064) |
0.2 | 4.4 | GO:0000785 | chromatin(GO:0000785) |
0.2 | 0.8 | GO:0044447 | axoneme part(GO:0044447) |
0.2 | 8.4 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.2 | 0.6 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.2 | 4.1 | GO:0043204 | perikaryon(GO:0043204) |
0.2 | 10.9 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 2.4 | GO:0097227 | sperm annulus(GO:0097227) |
0.2 | 1.3 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.2 | 13.5 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.2 | 6.0 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 0.7 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 1.8 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 0.9 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 17.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 1.4 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.2 | 0.5 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.2 | 16.5 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.2 | 5.5 | GO:0034707 | chloride channel complex(GO:0034707) |
0.2 | 6.3 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.2 | 1.7 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 2.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 3.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 1.2 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 0.7 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 3.5 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 2.1 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 7.7 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 3.7 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
0.1 | 2.6 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 0.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 3.4 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 2.0 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 1.2 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 139.2 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 2.2 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.3 | GO:0016013 | syntrophin complex(GO:0016013) |
0.1 | 1.6 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.1 | 3.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.5 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.8 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 11.3 | GO:0045202 | synapse(GO:0045202) |
0.1 | 2.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.6 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.1 | 1.9 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.2 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 0.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 7.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 5.2 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 8.2 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.4 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 1.7 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 1.2 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 0.5 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 8.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.5 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 1.2 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 21.3 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 21.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.6 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 0.2 | GO:0030131 | AP-type membrane coat adaptor complex(GO:0030119) clathrin adaptor complex(GO:0030131) |
0.1 | 5.0 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.5 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.6 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 25.5 | GO:0016604 | nuclear body(GO:0016604) |
0.0 | 3.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.2 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 0.8 | GO:0005929 | cilium(GO:0005929) |
0.0 | 1.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.5 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.0 | 0.3 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.1 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 1.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.1 | GO:0000788 | nuclear nucleosome(GO:0000788) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
29.2 | 87.7 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
26.5 | 79.6 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
9.8 | 39.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
7.2 | 50.4 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
6.7 | 20.2 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
5.6 | 39.2 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
5.4 | 21.5 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
5.1 | 15.4 | GO:0032090 | Pyrin domain binding(GO:0032090) |
4.9 | 4.9 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
4.9 | 250.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
4.6 | 27.6 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
4.6 | 13.7 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
4.2 | 16.6 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
3.7 | 11.1 | GO:0004103 | choline kinase activity(GO:0004103) |
3.7 | 11.1 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
3.6 | 17.9 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
3.6 | 32.2 | GO:0043426 | MRF binding(GO:0043426) |
3.5 | 14.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
3.3 | 10.0 | GO:0032089 | NACHT domain binding(GO:0032089) |
3.3 | 6.5 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
3.2 | 12.9 | GO:0031685 | adenosine receptor binding(GO:0031685) |
3.1 | 15.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
3.1 | 12.4 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
3.1 | 43.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
3.0 | 15.0 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
3.0 | 39.0 | GO:0042608 | T cell receptor binding(GO:0042608) |
3.0 | 15.0 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
2.9 | 14.3 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
2.8 | 8.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
2.6 | 17.9 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
2.4 | 7.3 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
2.4 | 7.3 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
2.4 | 7.1 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
2.4 | 11.9 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
2.4 | 9.5 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) ethanolaminephosphotransferase activity(GO:0004307) |
2.3 | 11.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
2.3 | 7.0 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
2.3 | 18.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
2.3 | 6.8 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
2.2 | 15.7 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
2.2 | 24.5 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
2.2 | 8.7 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
2.2 | 6.5 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
2.1 | 2.1 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
2.1 | 6.3 | GO:0050135 | NAD+ nucleosidase activity(GO:0003953) NAD(P)+ nucleosidase activity(GO:0050135) |
2.1 | 14.4 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
2.0 | 20.4 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
2.0 | 12.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
2.0 | 6.0 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
2.0 | 5.9 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
1.8 | 27.6 | GO:0015250 | water channel activity(GO:0015250) |
1.8 | 11.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
1.8 | 12.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
1.8 | 17.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.8 | 10.7 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
1.8 | 7.1 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
1.8 | 5.3 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
1.8 | 5.3 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
1.8 | 21.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.8 | 8.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
1.7 | 8.7 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
1.7 | 3.5 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
1.7 | 8.7 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
1.7 | 295.8 | GO:0003823 | antigen binding(GO:0003823) |
1.7 | 6.8 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
1.7 | 5.0 | GO:0019959 | interleukin-8 binding(GO:0019959) |
1.7 | 5.0 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
1.7 | 6.7 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
1.7 | 3.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
1.6 | 13.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.6 | 6.4 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
1.6 | 4.8 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
1.6 | 3.2 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
1.6 | 7.8 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
1.6 | 17.1 | GO:0008061 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
1.6 | 4.7 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
1.5 | 6.2 | GO:0035473 | lipase binding(GO:0035473) |
1.5 | 7.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.5 | 9.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
1.5 | 16.3 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
1.5 | 5.8 | GO:0008431 | vitamin E binding(GO:0008431) |
1.4 | 20.1 | GO:0004875 | complement receptor activity(GO:0004875) |
1.4 | 5.6 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
1.4 | 4.1 | GO:0098770 | FBXO family protein binding(GO:0098770) |
1.4 | 4.1 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
1.3 | 9.4 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
1.3 | 2.6 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
1.3 | 5.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.3 | 22.0 | GO:0038191 | neuropilin binding(GO:0038191) |
1.3 | 14.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
1.3 | 5.2 | GO:0035939 | microsatellite binding(GO:0035939) |
1.3 | 3.8 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
1.2 | 3.7 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
1.2 | 3.7 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
1.2 | 2.4 | GO:0048406 | nerve growth factor binding(GO:0048406) |
1.2 | 8.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
1.2 | 9.6 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
1.2 | 5.9 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
1.2 | 17.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
1.2 | 1.2 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
1.2 | 20.0 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
1.2 | 1.2 | GO:0000405 | bubble DNA binding(GO:0000405) |
1.2 | 4.6 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
1.2 | 6.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.1 | 6.9 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
1.1 | 5.7 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
1.1 | 9.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
1.1 | 5.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.1 | 4.5 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.1 | 5.6 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
1.1 | 15.5 | GO:0016594 | glycine binding(GO:0016594) |
1.1 | 4.3 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
1.1 | 3.2 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
1.1 | 3.2 | GO:0052595 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
1.0 | 9.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
1.0 | 7.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
1.0 | 8.3 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
1.0 | 6.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
1.0 | 4.1 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
1.0 | 4.1 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
1.0 | 26.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
1.0 | 14.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
1.0 | 10.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.0 | 8.1 | GO:0045159 | myosin II binding(GO:0045159) |
1.0 | 6.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
1.0 | 5.0 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
1.0 | 2.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.0 | 7.8 | GO:0048495 | Roundabout binding(GO:0048495) |
1.0 | 5.8 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
1.0 | 2.9 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.9 | 25.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.9 | 0.9 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.9 | 4.7 | GO:0017153 | succinate transmembrane transporter activity(GO:0015141) sodium:dicarboxylate symporter activity(GO:0017153) |
0.9 | 8.3 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.9 | 4.5 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.9 | 4.5 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.9 | 5.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.9 | 4.3 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.9 | 6.0 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.9 | 8.5 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.9 | 5.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.8 | 3.4 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.8 | 45.1 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.8 | 2.5 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
0.8 | 18.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.8 | 5.8 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.8 | 23.7 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.8 | 2.5 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
0.8 | 2.5 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.8 | 3.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.8 | 10.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.8 | 12.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.8 | 17.0 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.8 | 6.5 | GO:0030172 | troponin C binding(GO:0030172) |
0.8 | 4.0 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.8 | 4.8 | GO:0052811 | 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) |
0.8 | 4.8 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.8 | 21.3 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.8 | 3.1 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.8 | 11.5 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.8 | 19.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.8 | 6.0 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.7 | 3.7 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.7 | 3.0 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.7 | 18.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.7 | 2.9 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.7 | 7.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.7 | 16.7 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.7 | 2.1 | GO:0046997 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.7 | 4.2 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.7 | 8.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.7 | 10.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.7 | 2.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.7 | 9.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.7 | 2.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.7 | 7.3 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.7 | 2.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.7 | 3.3 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.7 | 5.9 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.6 | 5.2 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.6 | 2.6 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.6 | 16.8 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.6 | 5.8 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.6 | 1.9 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.6 | 24.1 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.6 | 2.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.6 | 7.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.6 | 19.2 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.6 | 3.1 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.6 | 1.2 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.6 | 4.9 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.6 | 1.8 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
0.6 | 3.7 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.6 | 1.2 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.6 | 3.7 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
0.6 | 6.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.6 | 5.4 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.6 | 1.8 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.6 | 4.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.6 | 2.3 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
0.6 | 1.7 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.6 | 2.3 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
0.6 | 8.0 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.6 | 4.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.6 | 1.7 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.6 | 3.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.6 | 1.7 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.6 | 5.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.6 | 10.6 | GO:0043495 | protein anchor(GO:0043495) |
0.6 | 2.2 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.6 | 8.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.5 | 8.8 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.5 | 13.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.5 | 10.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.5 | 2.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.5 | 1.6 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.5 | 9.7 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.5 | 2.2 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.5 | 2.2 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.5 | 3.2 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.5 | 2.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.5 | 2.6 | GO:0004359 | glutaminase activity(GO:0004359) |
0.5 | 6.8 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.5 | 2.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.5 | 6.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.5 | 30.4 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.5 | 11.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.5 | 5.6 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.5 | 2.0 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.5 | 1.5 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.5 | 2.0 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.5 | 2.5 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.5 | 16.5 | GO:0008009 | chemokine activity(GO:0008009) |
0.5 | 2.0 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.5 | 1.5 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.5 | 6.9 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.5 | 4.9 | GO:0051425 | PTB domain binding(GO:0051425) |
0.5 | 3.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.5 | 5.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.5 | 2.9 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) peptidyl-dipeptidase activity(GO:0008241) |
0.5 | 12.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.5 | 5.8 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.5 | 14.0 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.5 | 1.4 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.5 | 2.4 | GO:0005497 | androgen binding(GO:0005497) |
0.5 | 3.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.5 | 18.0 | GO:0015026 | coreceptor activity(GO:0015026) |
0.5 | 5.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.5 | 5.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.5 | 3.7 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.5 | 19.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.5 | 1.9 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.5 | 0.9 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.5 | 1.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.5 | 16.1 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.5 | 5.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.5 | 2.8 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.5 | 1.8 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.5 | 44.8 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.4 | 2.7 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.4 | 4.0 | GO:0031419 | cobalamin binding(GO:0031419) |
0.4 | 1.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.4 | 4.4 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.4 | 0.9 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.4 | 3.5 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.4 | 3.9 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.4 | 7.4 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.4 | 8.2 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.4 | 2.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.4 | 4.7 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.4 | 1.7 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.4 | 12.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.4 | 5.4 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.4 | 1.6 | GO:0042020 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.4 | 10.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.4 | 1.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.4 | 1.6 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.4 | 42.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.4 | 4.8 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.4 | 19.2 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.4 | 5.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.4 | 3.2 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.4 | 4.7 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.4 | 3.6 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.4 | 3.1 | GO:0031491 | nucleosome binding(GO:0031491) |
0.4 | 5.8 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.4 | 6.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.4 | 1.1 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.4 | 1.5 | GO:0036033 | mediator complex binding(GO:0036033) |
0.4 | 3.4 | GO:0048156 | tau protein binding(GO:0048156) |
0.4 | 0.4 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.4 | 3.3 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.4 | 4.8 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.4 | 18.4 | GO:0030507 | spectrin binding(GO:0030507) |
0.4 | 4.4 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.4 | 11.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.4 | 1.5 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.4 | 2.6 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.4 | 2.9 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.4 | 3.9 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.4 | 4.6 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.4 | 10.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.3 | 3.5 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.3 | 2.4 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.3 | 40.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.3 | 10.4 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.3 | 3.4 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.3 | 3.8 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.3 | 1.7 | GO:0002046 | opsin binding(GO:0002046) |
0.3 | 1.0 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.3 | 2.3 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.3 | 4.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.3 | 2.9 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.3 | 22.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.3 | 1.0 | GO:0004040 | amidase activity(GO:0004040) |
0.3 | 2.9 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.3 | 1.6 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
0.3 | 2.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 7.0 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.3 | 95.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.3 | 5.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.3 | 3.4 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.3 | 1.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 6.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.3 | 2.4 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.3 | 1.5 | GO:0045125 | sphingosine-1-phosphate receptor activity(GO:0038036) bioactive lipid receptor activity(GO:0045125) |
0.3 | 3.0 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.3 | 3.3 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.3 | 7.8 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.3 | 1.5 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.3 | 1.5 | GO:0051373 | FATZ binding(GO:0051373) |
0.3 | 0.9 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
0.3 | 2.6 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.3 | 8.1 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.3 | 1.7 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.3 | 1.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.3 | 4.9 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 1.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.3 | 1.7 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.3 | 13.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.3 | 2.8 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.3 | 0.8 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.3 | 4.8 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.3 | 1.7 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.3 | 3.6 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.3 | 3.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.3 | 0.8 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
0.3 | 1.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.3 | 2.9 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.3 | 1.9 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.3 | 2.4 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 3.9 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.3 | 2.9 | GO:0030955 | potassium ion binding(GO:0030955) |
0.3 | 5.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.3 | 1.8 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.3 | 3.8 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.3 | 6.3 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.2 | 3.2 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 1.0 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.2 | 3.5 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.2 | 2.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 4.9 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.2 | 4.3 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.2 | 0.7 | GO:0005267 | potassium channel activity(GO:0005267) |
0.2 | 2.1 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 0.9 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.2 | 2.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 5.4 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.2 | 6.7 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.2 | 1.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.2 | 3.6 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 7.9 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.2 | 3.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.2 | 4.2 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.2 | 3.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 1.3 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.2 | 5.9 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.2 | 1.5 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.2 | 0.4 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.2 | 2.3 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 0.6 | GO:0070984 | SET domain binding(GO:0070984) |
0.2 | 8.5 | GO:0005261 | cation channel activity(GO:0005261) |
0.2 | 3.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 0.8 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.2 | 2.4 | GO:0005542 | folic acid binding(GO:0005542) |
0.2 | 4.5 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.2 | 2.9 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.2 | 4.1 | GO:0030371 | translation repressor activity(GO:0030371) |
0.2 | 5.6 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 5.9 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.2 | 118.4 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) |
0.2 | 0.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 1.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 1.7 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 0.9 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 0.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 2.6 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.2 | 1.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 0.9 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 2.2 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.2 | 1.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.2 | 1.2 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 0.9 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
0.2 | 1.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.2 | 1.7 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.2 | 0.5 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.2 | 1.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 1.0 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.2 | 0.7 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.2 | 1.6 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.2 | 2.4 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.2 | 100.7 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.2 | 1.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.4 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 2.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 2.6 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 3.3 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.4 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.9 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 3.6 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 2.2 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.1 | 5.1 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 1.7 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 1.2 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.8 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.9 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 3.7 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 2.1 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.1 | 0.9 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.5 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 20.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 1.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 2.8 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.1 | 0.6 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 2.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 1.0 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 1.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 1.8 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 0.2 | GO:0097259 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
0.1 | 0.9 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.5 | GO:0086077 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.1 | 3.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.5 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.4 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.1 | 1.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.8 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.1 | 0.9 | GO:0015926 | glucosidase activity(GO:0015926) |
0.1 | 0.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 1.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 9.3 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.1 | 4.1 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.1 | 1.3 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.1 | 1.1 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.1 | 0.5 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 0.2 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.1 | 0.4 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.1 | 0.5 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.1 | 1.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.9 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 2.6 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.6 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 1.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 8.0 | GO:0000149 | SNARE binding(GO:0000149) |
0.1 | 1.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 1.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 4.8 | GO:0008186 | RNA-dependent ATPase activity(GO:0008186) |
0.1 | 1.8 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.1 | 0.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 1.8 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 4.8 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.1 | 1.9 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.1 | 0.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 1.0 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 3.0 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 1.9 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 37.2 | GO:0004872 | receptor activity(GO:0004872) molecular transducer activity(GO:0060089) |
0.1 | 0.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 0.8 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.3 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.3 | GO:0039552 | RIG-I binding(GO:0039552) |
0.0 | 0.3 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.0 | 1.0 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.0 | 0.3 | GO:0000150 | recombinase activity(GO:0000150) |
0.0 | 0.2 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.7 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 1.1 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.0 | 0.4 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.9 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.0 | 0.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.4 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.0 | 0.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.6 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.4 | GO:0008146 | sulfotransferase activity(GO:0008146) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.4 | 119.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.9 | 5.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
1.7 | 67.8 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
1.6 | 30.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.6 | 12.8 | PID FOXO PATHWAY | FoxO family signaling |
1.5 | 7.4 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
1.3 | 11.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
1.2 | 12.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.2 | 25.4 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
1.1 | 71.7 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
1.1 | 19.3 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
1.1 | 40.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
1.1 | 5.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
1.0 | 15.6 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
1.0 | 7.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.9 | 30.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.9 | 31.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.9 | 41.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.9 | 24.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.8 | 50.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.8 | 29.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.8 | 70.9 | PID BCR 5PATHWAY | BCR signaling pathway |
0.8 | 3.9 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.7 | 2.9 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.7 | 37.6 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.7 | 20.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.7 | 20.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.6 | 19.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.6 | 1.8 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.6 | 40.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.6 | 30.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.5 | 4.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.5 | 5.2 | PID EPO PATHWAY | EPO signaling pathway |
0.5 | 10.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.5 | 1.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.5 | 12.1 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.5 | 21.6 | PID ENDOTHELIN PATHWAY | Endothelins |
0.5 | 7.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.5 | 12.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.4 | 11.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.4 | 6.1 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.4 | 2.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.4 | 1.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.4 | 7.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.4 | 5.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.4 | 9.7 | PID ARF6 PATHWAY | Arf6 signaling events |
0.4 | 9.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.4 | 21.9 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.3 | 10.6 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.3 | 4.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.3 | 3.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.3 | 2.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.3 | 2.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.3 | 3.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 8.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.3 | 3.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.3 | 1.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.3 | 2.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.3 | 10.8 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.3 | 6.2 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.3 | 4.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.3 | 4.3 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 41.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 5.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.2 | 9.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.2 | 6.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 8.2 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 1.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 0.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 0.8 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 66.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.2 | 3.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 4.0 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 11.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 2.7 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 7.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.2 | 2.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 1.5 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 0.6 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.2 | 4.0 | PID FGF PATHWAY | FGF signaling pathway |
0.2 | 4.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 3.3 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 2.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 5.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 12.0 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 1.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 1.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 3.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 1.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 3.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 0.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.5 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 0.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.5 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.5 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.6 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 74.2 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
2.4 | 54.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
2.1 | 39.6 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
1.9 | 26.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.8 | 43.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
1.7 | 19.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
1.5 | 23.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
1.5 | 3.0 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
1.5 | 136.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
1.5 | 29.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.3 | 25.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
1.3 | 16.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
1.3 | 42.6 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.1 | 22.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
1.1 | 85.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
1.1 | 5.3 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
1.0 | 10.1 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
1.0 | 10.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.9 | 15.9 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.9 | 2.6 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.9 | 13.0 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.8 | 6.3 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.8 | 9.3 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.8 | 48.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.7 | 14.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.7 | 8.5 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.7 | 26.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.7 | 31.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.6 | 4.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.6 | 6.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.6 | 8.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.6 | 19.1 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.6 | 5.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.6 | 7.2 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.6 | 5.4 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.6 | 7.7 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.6 | 24.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.6 | 10.3 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.6 | 2.3 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.6 | 3.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.6 | 3.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.5 | 4.8 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.5 | 7.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.5 | 8.9 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.5 | 0.5 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.5 | 1.9 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.5 | 14.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.5 | 15.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.5 | 5.2 | REACTOME OPSINS | Genes involved in Opsins |
0.5 | 11.5 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.5 | 22.6 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.4 | 6.6 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.4 | 8.3 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.4 | 13.2 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.4 | 17.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.4 | 11.1 | REACTOME PLATELET HOMEOSTASIS | Genes involved in Platelet homeostasis |
0.4 | 9.1 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.4 | 4.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.4 | 38.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.4 | 8.9 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.4 | 6.9 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.4 | 7.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.4 | 29.0 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.4 | 11.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.4 | 8.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.4 | 4.2 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.3 | 1.7 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.3 | 8.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.3 | 38.5 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.3 | 2.7 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 15.7 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.3 | 29.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.3 | 2.8 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.3 | 4.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.3 | 1.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 1.5 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.3 | 4.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.3 | 46.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 14.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.3 | 3.3 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.3 | 5.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.3 | 3.9 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.3 | 1.0 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 0.5 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.2 | 2.5 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.2 | 2.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.2 | 5.8 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.2 | 2.6 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 6.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.2 | 15.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 6.5 | REACTOME SIGNALING BY FGFR MUTANTS | Genes involved in Signaling by FGFR mutants |
0.2 | 6.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 7.1 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.2 | 1.7 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 4.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 5.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 4.4 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.2 | 3.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 0.5 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.2 | 4.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 1.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.2 | 1.6 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.2 | 3.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 0.6 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 5.0 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 2.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 4.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 2.6 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.1 | 0.9 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 12.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 1.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 2.7 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 1.1 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 3.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 11.5 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 1.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 1.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 3.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.4 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 3.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 2.6 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 1.8 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.1 | 1.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 4.1 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 0.8 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 1.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 1.2 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 7.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 3.1 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 0.9 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 1.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 1.6 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 11.3 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 1.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 1.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 2.6 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.8 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.6 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 1.0 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.0 | 0.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 1.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |